Also trades as: 0QCV.L (LSE) · $vol 3M · 4AB.DE (XETRA) · $vol 0M · ABBV.BA (BUE) · $vol 0M · 4AB.DU (DUS) · $vol 0M
ABBV NYSE
AbbVie Inc.
1W: +1.8%
1M: +7.0%
3M: -4.5%
YTD: -5.7%
1Y: +17.9%
3Y: +64.1%
5Y: +118.8%
$215.70
+1.20 (+0.56%)
Weekly Expected Move ±3.7%
$195
$203
$210
$218
$226
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
2 bullish
0 neutral
0 bearish
Articles (24h)
2
Hourly Sentiment (24h)
0.40
Bullish
6 bullish
1 neutral
2 bearish
Articles (7d)
9
Daily Sentiment (7 Days)
Articles (100)
Healthcare Stocks Are on Fire -- Don't Miss These Opportunities
Opinion: AbbVie Is the Best Dividend King to Buy in an Increasingly Uncertain Market
GSK Stock Declines 9% in a Month: Time to Buy, Hold or Exit?
J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth
2 Stocks That Are Much Cheaper Than They Look
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts
Supreme Court Hands Major Blow To Big Pharma's Fight Against Biden-Era Medicare Drug Pricing Law
Here's How Neuroscience Drugs Boost AbbVie's Q1 Sales Growth
Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?
ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook
ANIP Valuation: Does 9.8x Forward P/E Offer Upside?
ANIP Stock: What's Driving Cortrophin Gel's 2026 Surge
How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?
Mega‑cap laggards: IBM, Palantir, Wells Fargo lead biggest YTD declines
5 Stocks to Own For the Next 10 Years
CNS Drug Delivery Technologies Are Reshaping Alzheimer's and Biodefense Research
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio
Top Stock Reports for NVIDIA, Mastercard & AbbVie
3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow
A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?
Trump says unaware of a plan to fire FDA commissioner
Ironwood Stock Down Despite Q1 Earnings and Revenue Beat
Trump to fire FDA commissioner Marty Makary: WSJ
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?
Want Reliable Dividend Income in May? These 2 Stocks Deliver
Apple, Amazon, TSMC Top List Of Earnings Triple Plays As Beat-And-Raise Stocks Surge
Apple, Amazon, TSMC Top List Of Earnings Triple Plays As Beat-And-Raise Stocks Surge
Want to Collect a High Dividend Every Month? Invest in These 3 Stocks
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook
3 of the Best Dividend Stocks to Buy in May 2026
ABBV Stock Up 5% on Robust Q1 Performance: Time to Buy, Sell or Hold?
The Best Stocks to Buy With $1,000 Right Now
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
Earnings Scoreboard: 82% of S&P 500 reporting firms top EPS estimates as 78% of firms post Y/Y earnings growth
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat
Netflix, Cisco, Zoom And A Health Care Stock On CNBC's 'Final Trades'
Company News for Apr 30, 2026
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
AbbVie signals $14.08-$14.28 2026 adjusted EPS as Skyrizi and Rinvoq outlook rises
AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength
AbbVie (ABBV) Q1 2026 Earnings Transcript
ABBV Beats on Q1 Earnings & Sales, Raises '26 EPS View
All Eyes on Four Key "Mag 7" Earnings Results
AbbVie (ABBV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
AbbVie Q1 2026 Earnings Call: Complete Transcript
Near the top of biotech rankings, AbbVie's Q1 beat makes a case for more upside
ABBV Seeks FDA Nod for Rinvoq Label Expansion in Alopecia Areata
Big Boosts to Econ Growth from AI Investment, Inventories & More
AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?
AbbVie (ABBV) Tops Q1 Earnings and Revenue Estimates
AbbVie hikes 2026 outlook as Skyrizi, Rinvoq offset Humira slump
Earnings Snapshot: AbbVie beats Q1 revenue estimates, misses on profit; raises FY26 outlook
AbbVie in charts: Q1 Revenues from Humira -39%, Skyrizi +31%, Rinvoq +23% Y/Y
AbbVie Non-GAAP EPS of $2.65 misses by $0.02, revenue of $15B beats by $280M
AbbVie Reports First-Quarter 2026 Financial Results
Earnings Scheduled For April 29, 2026
Here are the major earnings before the open Wednesday
Should You Buy AbbVie Stock Hand Over Fist Before April 29?
AbbVie says Rinvoq bests Humira in head-to-head study in rheumatoid arthritis
AbbVie Q1 Preview: Skyrizi, Rinvoq expected to drive growth recovery
AbbVie Inc. $ABBV Shares Sold by Arlington Trust Co LLC
Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch
Will These 5 Drug Bigwigs Surpass Q1 Earnings Forecasts?
AbbVie submits application to FDA for subcutaneous Skyrizi
Only 11 mega-caps stand out in SA Quant Ratings as markets hover near highs
Comerica Bank Trims Stock Position in AbbVie Inc. $ABBV
Is Bristol Myers Squibb the Best Bargain in Big Pharma?
AbbVie Inc. $ABBV Shares Bought by D.A. Davidson & CO.
Aprio Wealth Management LLC Purchases 4,502 Shares of AbbVie Inc. $ABBV
Anchyra Partners LLC Buys Shares of 5,056 AbbVie Inc. $ABBV
Earnings week ahead: MSFT, AAPL, GOOG, AMZN, META, XOM, CVX, KO, V, SBUX, F, GM, and more
Axecap Investments LLC Increases Stock Position in AbbVie Inc. $ABBV
Advisors Capital Management LLC Purchases 20,147 Shares of AbbVie Inc. $ABBV
AEGON ASSET MANAGEMENT UK Plc Sells 20,049 Shares of AbbVie Inc. $ABBV
Abacus FCF Advisors LLC Decreases Position in AbbVie Inc. $ABBV
Calamos Advisors LLC Grows Stock Holdings in AbbVie Inc. $ABBV
Catalyst Watch: Earnings blitz, FOMC, Pershing Square IPO, and NYC gets a full casino
AbbVie's TrenibotE Receives FDA CRL Due to Manufacturing Issues
Insights Into AbbVie (ABBV) Q1: Wall Street Projections for Key Metrics
4 stocks to watch on Friday: PG, LLY, MSFT, ABBV
AbbVie Faces FDA Rejection On Manufacturing Issues For Wrinkle Drug
AbbVie anti-wrinkle therapy rejected at FDA
Atwood & Palmer Inc. Has $44.41 Million Stake in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Arizona State Retirement System
Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
AbbVie Q1 Earnings Loom: Buy or Sell the Stock Ahead of Results?
B. Metzler seel. Sohn & Co. AG Purchases 335,055 Shares of AbbVie Inc. $ABBV
AbbVie announces new $1.4B manufacturing campus in North Carolina
Should You Forget Pfizer and Buy This Pharma Stock Instead?
AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
J&J Innovative Medicine Drives Q1 Strength: Key to Long-Term Growth?
Clarity Financial LLC Sells 23,870 Shares of AbbVie Inc. $ABBV
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly
DSG Capital Advisors LLC Buys 5,090 Shares of AbbVie Inc. $ABBV
Alley Investment Management Company LLC Sells 6,845 Shares of AbbVie Inc. $ABBV
Here's Why AbbVie (ABBV) Fell More Than Broader Market
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New Generics